Bromodeoxyuridine and deoxyribonucleic acid bivariate analysis in human renal cell carcinoma. Does flow cytometric determination predict malignant potential or prognosis of patients with renal cell carcinoma? | Canada Hyperbarics Skip to main content
Study Am J Clin Pathol 1992

Bromodeoxyuridine and deoxyribonucleic acid bivariate analysis in human renal cell carcinoma. Does flow cytometric determination predict malignant potential or prognosis of patients with renal cell carcinoma?

Tachibana M, Deguchi N, Baba S, Jitsukawa S, Hata M, Tazaki H — Am J Clin Pathol, 1992

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers analyzed 61 kidney cancer samples using a method involving DNA and bromodeoxyuridine labeling, performed under hyperbaric oxygen.

What They Found

They found that DNA ploidy correlated with distant cancer spread. Tumors that were solid, high-grade, or had spread showed a significantly higher bromodeoxyuridine labeling index (LI). Five patients who died had a significantly higher mean LI of 11.5% compared to 56 survivors who had a mean LI of 6.7%. However, these results did not consistently predict cancer severity or patient outlook for individual cases.

What This Means for Canadian Patients

This study explored a diagnostic method for renal cell carcinoma, a type of kidney cancer. While the method involved hyperbaric oxygen during sample preparation, the study did not evaluate HBOT as a treatment. The findings suggest this specific diagnostic approach was inconsistent in predicting cancer potential or patient prognosis.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study's main limitation was that the analysis did not consistently predict the cancer's severity or patient prognosis in individual cases.

Was this summary helpful?

Study Details

Study Type Study
Category Aging & Longevity
Source Pubmed
PubMed ID 1575219
Year Published 1992
Journal Am J Clin Pathol
MeSH Terms Bromodeoxyuridine; Carcinoma, Renal Cell; DNA, Neoplasm; Flow Cytometry; Humans; Kidney Neoplasms; Neoplasm Staging; Ploidies; Prognosis

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.